Pfizer (PFE) Tops Q1 EPS by 15c, Guidance Misses Consensus

Pfizer (NYSE: PFE) reported Q1 EPS of $1.62, $0.15 better than the analyst estimate of $1.47. Revenue for the quarter came in at $25.7 billion versus the consensus estimate of $23.86 billion.

GUIDANCE:

Pfizer sees FY2022 EPS of $6.25-$6.45, versus the consensus of $7.15. Pfizer sees FY2022 revenue of $98-102 billion, versus the consensus of $107.9 billion.

For earnings history and earnings-related data on Pfizer (PFE) click here.

You May Also Be Interested In

• monday.com Ltd. (MNDY) Tops Q2 EPS by 37c; offers guidance
• Lincoln Educational Services (LINC) PT Lowered to $50 at Rosenblatt
• Pfizer (PFE) PT Lowered to $29 at Bernstein SocGen Group